beta-amyrin has been researched along with scopolamine hydrobromide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, YJ; Jang, DS; Jung, JW; Kwon, G; Lee, HE; Lee, Y; Oh, SR; Park, SJ; Ryu, JH; Woo, H | 1 |
1 other study(ies) available for beta-amyrin and scopolamine hydrobromide
Article | Year |
---|---|
Amyrin attenuates scopolamine-induced cognitive impairment in mice.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; MAP Kinase Signaling System; Memory; Mice, Inbred ICR; Muscarinic Antagonists; Oleanolic Acid; Scopolamine | 2014 |